Custom Cell Therapy Strategies to Lower CGT Production Expenses with Thermo Fisher
T&L Biotechnology Co., Ltd. is proud to present innovative cell therapy strategies aimed at reducing the production expenses of cell and Gene Therapy (CGT) products. Our cutting-edge technologies and solutions are designed to optimize the entire manufacturing process, from cell expansion and gene editing to final product formulation, With the increasing demand for CGT products, it is essential to develop cost-efficient production methods without compromising the quality and safety of the final therapies. At T&L Biotechnology, we have developed proprietary techniques that allow for efficient cell expansion and gene modification, resulting in higher yields and reduced production costs
